| Identification | Back Directory | [Name]
[9a,9'a(2H,2'H)-Binaphtho[2,3-b]furan]-2,2'-dione, 4,4',4a,4'a,5,5',6,6',7,7',8,8',8a,8'a,9,9'-hexadecahydro-3,3',8a,8'a-tetramethyl-5,5'-bis(methylene)-, (4aR,4'aR,8aS,8'aS,9aR,9'aR)- | [CAS]
182426-37-5 | [Synonyms]
Biatractylolide
Biatractylenolide
[9a,9'a(2H,2'H)-Binaphtho[2,3-b]furan]-2,2'-dione, 4,4',4a,4'a,5,5',6,6',7,7',8,8',8a,8'a,9,9'-hexadecahydro-3,3',8a,8'a-tetramethyl-5,5'-bis(methylene)-, (4aR,4'aR,8aS,8'aS,9aR,9'aR)- | [Molecular Formula]
C30H38O4 | [MOL File]
182426-37-5.mol | [Molecular Weight]
462.63 |
| Hazard Information | Back Directory | [Uses]
Biatractylolide is a compound isolated from the ethyl acetate extract of Atractylodes macrocephala. Biatractylolide has antitumor and antioxidant activities. Biatractylolide improves cell viability, inhibits the apoptosis of cells induced by glutamate, and reduces the activity of LDH. Biatractylolide has neuroprotective effects[1]. | [References]
[1] Zhu L, et al. Biatractylolide Modulates PI3K-Akt-GSK3β-Dependent Pathways to Protect against Glutamate-Induced Cell Damage in PC12 and SH-SY5Y Cells. Evid Based Complement Alternat Med. DOI:10.1155/2017/1291458 |
|
|